| __timestamp | Bausch Health Companies Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 22223073 |
| Thursday, January 1, 2015 | 582800000 | 6966842 |
| Friday, January 1, 2016 | 455000000 | 9000499 |
| Sunday, January 1, 2017 | 366000000 | 13741186 |
| Monday, January 1, 2018 | 414000000 | 19040000 |
| Tuesday, January 1, 2019 | 471000000 | 23559000 |
| Wednesday, January 1, 2020 | 452000000 | 31931000 |
| Friday, January 1, 2021 | 465000000 | 44981000 |
| Saturday, January 1, 2022 | 529000000 | 54234000 |
| Sunday, January 1, 2023 | 604000000 | 63806000 |
Cracking the code
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Bausch Health Companies Inc. and Viking Therapeutics, Inc. have shown contrasting approaches in their R&D investments.
Bausch Health, a giant in the industry, has consistently invested heavily in R&D, with a notable 145% increase from 2014 to 2023. Their spending peaked in 2023, reflecting a strategic push towards new product development. In contrast, Viking Therapeutics, a smaller player, has shown a remarkable growth trajectory, with R&D expenses increasing nearly threefold over the same period.
This data highlights the dynamic nature of the pharmaceutical industry, where both established giants and emerging innovators are racing to develop the next breakthrough treatment.
Research and Development Investment: Sanofi vs Bausch Health Companies Inc.
Research and Development: Comparing Key Metrics for argenx SE and Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Viking Therapeutics, Inc.
Viking Therapeutics, Inc. or CRISPR Therapeutics AG: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs HUTCHMED (China) Limited
Research and Development Investment: Viking Therapeutics, Inc. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs Xencor, Inc.
Analyzing R&D Budgets: Veracyte, Inc. vs Bausch Health Companies Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. Allocate Funds
Research and Development Expenses Breakdown: Bausch Health Companies Inc. vs Mesoblast Limited
Analyzing R&D Budgets: Bausch Health Companies Inc. vs Ligand Pharmaceuticals Incorporated